Publications by authors named "M Krengli"

Purpose: Radiotherapy (RT) plays a crucial role in head and neck (HN) cancer treatment. Nevertheless, it can lead to serious and challenging adverse events such as osteoradionecrosis (ORN). A preclinical rabbit model of irradiated bone and ORN is herein proposed, with the aim to develop a viable model to be exploited for investigating new therapeutic approaches.

View Article and Find Full Text PDF

Introduction: Recent evidence supports the efficacy of surgical navigation (SN) in improving outcomes of sinonasal and craniofacial oncologic surgery. This study aims to demonstrate the utility of SN as a tool for integrating surgical, radiologic, and pathologic information. Additionally, a system for recording and mapping biopsy samples has been devised to facilitate sharing of spatial information.

View Article and Find Full Text PDF

Angiosarcoma (AS) represents a rare and aggressive vascular sarcoma, posing distinct challenges in clinical management compared to other sarcomas. While the current European Society of Medical Oncology (ESMO) clinical practice guidelines for sarcoma treatment are applicable to AS, its unique aggressiveness and diverse tumor presentations necessitate dedicated and detailed clinical recommendations, which are currently lacking. Notably, considerations regarding surgical extent, radiation therapy (RT), and neoadjuvant/adjuvant chemotherapy vary significantly in localized disease, depending on each different site of onset.

View Article and Find Full Text PDF
Article Synopsis
  • Kaposi's sarcoma (KS) is a rare tumor with four clinical forms, diagnosed through histopathological and immunohistochemical analyses, and treated using a mix of local and systemic methods.
  • A retrospective study analyzed 86 KS patients treated over 29 years, showing that most were male and had the classical variant, with surgery and chemotherapy being the common treatments.
  • The study found a persistent treatment response in about 65% of patients, a 22% relapse rate, and an overall survival rate of 90% to 70% over 2 to 10 years, emphasizing the need for a multidisciplinary approach to manage the disease effectively.
View Article and Find Full Text PDF

Primary vascular tumors of bone are a heterogeneous group of neoplasms, ranging from benign hemangiomas to frankly malignant epithelioid hemangioendotheliomas and angiosarcomas. Over the years, their classification has been a matter of discussion, due to morphologic similarities and uncertainty regarding biologic behavior. Over the past decade, with the development of next-generation sequencing, there has been a significant improvement in the molecular characterization of these lesions.

View Article and Find Full Text PDF